Effect of tenuigenin on cholinergic decline induced by β-amyloid peptide and ibotenic acid in rats

Yaoxue Xuebao

Volumn 37, Issue 12, 2002, Pages 913-917

  Chen, Qin ^a   Cao, Yan Gui ^a   Zhang, Chuan Hui ^a  

^a ANHUI UNIVERSITY   (China)

Author keywords

Amyloid peptide; AChE; ChAT; Dementia like model; Learning and memory; Muscarinic receptor density; Tenuigenin

Indexed keywords

EID: 0042236570     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Wu P, Du Qy, Hu RZ, et al. The chemical, pharmacological and clinical research for Polygala tenuifolia Willd. [J]. J Strait Pharm, 1999,11(2):108 -109.
2. Li WK, Liang XY. The component and pharmacological activity of saponins in the officinal plant of Polygala L. [J]. World Phytomed, 1998,13(2): 60-62.
3. Chen Q, Hu YE, Xia ZQ. Effect of ZMS on demented model by injection of beta-amyloid to right nucleus basalis [J]. Acta Univ Med Second Shanghai, 2001,21(5):401-403.
4. Zhang JT, Saito H. Studies on susceptibilities to the amnestic effects of 12 chemicals on passive avoidance responses in mice: comparison between step down and step through tests [J]. Acta Pharm Sin, 1986,21(1):12-16.
5. Chen Q. The Experimental Methods for Antiaging Research [M]. Beijing: China Medico-Pharm Aceutical Science and Technology Publishing House, 1996.108-110.
6. Leventer S, Mckeag D, Clancy M, et al. Intracerebroventricular administration of ethyl-choline mustard aziridinium ion (AF64A) reduces release of acetylcholine from rat hippocampal slices [J]. Neuropharmacology, 1985, 24(5):453-459.
7. Irizarry MC, Hyman BT. Alzheimer disease therapeutics [J]. J Neuropathol Exp Neurol, 2001,60(10):923-928.
8. Lemiere J, Van Gool D, Dom R. Treatment of Alzheimer's disease: an evaluation of the cholinergic approach [J]. Acta Neurol Belg, 1999,99(2):96-106.
9. Yamada K, Ren X, Nabeshima T. Perspectives of pharmacotherapy in Alzheimer's disease [J]. Jpn J Pharmacol, 1999,80(1):9-14.
10. Nitta A, Fukuta T, Hasegawa T, et al. Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration [J]. Jpn J Pharmacol, 1997,73(1):51-57.
11. Pavia J, Alberch J, Alvarez I, et al. Repeated intracerebroventricular administration of beta-amyloid (25-35) to rats decreases muscarinic receptors in cerebral cortex [J]. Neurosci Lett, 2000,278(1-2):69-72.
12. 24) 25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation [J]. Behav Brain Res, 1998,90(2):133-145.
13. Morimoto K, Yoshimi K, Tonohiro T, et al. Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons [J]. Neurosci, 1998,84(2):479-487.
14. Giovanelli L, Scali C, Faussone-Pellegrini MS, et al. Long-term changes in the aggregation state and toxic effects of beta-amyloid injected into the rat brain [J]. Neurosci, 1998,87 (2):349-357.
15. Page KJ, Everitt BJ, Robbins TW. Dissociable effects on spatial maze and passive aviodance acquisition and retention following AMPA- and ibotenic acid-induced excitotoxic lesion of basal forebrain in rats: differential dependence on cholinergic neuronal loss [J]. Neurosci, 1991,43(3):457-472.
16. Dornan WA, Kang DE, McCampbell A, et al. Biolateral injections of beta A (25-35) + IBO into the himppocampus disrups acquisition of spatial learning in the rat [J]. Neuroreport, 1993,5(2):165-168.